Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial
No Label: Geoff Kerchner Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche, Basel, Switzerland, discusses the...
Radio and PodcastLive Radio & PodcastsHealth
NeuroFrontiers
NeuroFrontiers is produced in collaboration with the American Academy of Neurology and explores new research, diagnosis and treatment in all areas of neurological disease. This series also a...
Episodes
20 of 192 episodesSubcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
No Label: Michael Irizarry, MD, MPH Dr. Michael Irizarry, Senior Vice-President, Clinical Research, Eisai, Nutley, NJ, discusses the evidenc...
Next-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease
No Label: Luka Kulic, MD In this episode, Luka Kulic, MD, Vice President and Global Head of Early Clinical Development in Neuroscience and R...
Advancing MOGAD Care
No Label: Michael Levy, MD, PhD No Label: Peter V. Sguigna, MD What do the latest METEOROID trial results mean for neurologists treating mye...
Multidisciplinary Coordination in TK2d Diagnosis and Management
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Zarazuela Zolkipli-Cunningham, MBChB, MRCP Guest: Oscar H. (Hank) Mayer, MD Thymidine kinase...
Navigating Stem Cell Therapy Conversations in MS
Guest: Jaime Imitola, MD As stem cell therapies continue to generate significant interest among patients with multiple sclerosis (MS), clini...
Cognitive Screening in MS: Practical Strategies and Modern Approaches
Guest: Elizabeth S. Gromisch, PhD Cognitive changes are a common but complex aspect of multiple sclerosis care, making practical and accessi...
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Bethany Lussier, MD Patients often present with respiratory symptoms that don’t quite align...
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
Host: Alexandria May, PharmD, BCPS Guest: Kaitlin Batley, MD Fatigue and muscle weakness may seem routine, but when do they signal an underl...
Understanding Variability in Myasthenia Gravis
Guest: Henry Kaminski, MD Myasthenia gravis is an unpredictable condition, with symptoms and treatment responses that can vary widely from o...
Examining the Global Genetic Prevalence of TK2d
Host: Brian P. McDonough, MD, FAAFP Guest: Austin Larson, MD Emerging research on thymidine kinase 2 deficiency (TK2d) provides new insights...
Advances in Cell-Based Therapy for MS
Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC Cxplore how cell-based therapies are reshaping treatment strategies for multiple scle...
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC The role of cell-based therapies in multiple sclerosis (MS) is evolving, with immune...
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Guest: Aaron Miller, MD Early real-world experience with the 2024 McDonald criteria suggests a meaningful increase in multiple sclerosis (MS...
Proactive Pregnancy Planning and Reproductive Care in MS
Guest: Riley Bove, MD, MMSc Multiple sclerosis (MS) is often diagnosed during peak reproductive years, making proactive, informed care essen...
Advancing Pediatric MS Care: Insights from AAN 2026
Guest: Elizabeth Wilson, MD At the 2026 American Academy of Neurology (AAN) Annual Meeting, experts are sharing the latest developments in p...
Updates in MS Care: Key Topics at AAN 2026
Guest: Aaron Miller, MD Hear from Dr. Aaron Miller as he shares important updates in multiple sclerosis (MS) at the 2026 American Academy of...
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
Guest: Adil Harroud, MD Guest: Dylan Hamitouche Host: Ryan Quigley Multimodal aging signatures are reshaping our understanding of progressio...
Understanding Accelerated Biological Aging in Pediatric MS
Guest: Jennifer Yang, MD Emerging evidence shows that children with multiple sclerosis exhibit accelerated biological aging. Learn more abou...
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
Guest: Raphael Schneider, MD, PhD, FRCPC, CIP Multiplex proteomic biomarker panels are redefining how we understand and monitor multiple scl...